ABBOTT LABORATORIES (ABT)
A+
Pipeline Grade
Financial Position (from SEC Filings)
$6,803.0M
Cash & Equivalents
$1,315.0M
Quarterly Burn Rate
$163,608M
Market Cap
Estimated from most recent SEC quarterly filing. View SEC filings
Drug Pipeline (47 Assets)
| Drug | Phase | Indications |
|---|---|---|
|
METHYLPREDNISOLONE SODIUM SUCCINATE
A-METHAPRED |
APPROVED | — |
|
CALCIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, SODIUM LACTATE
LACTATED RINGER'S IN PLASTIC CONTAINER |
NDA | — |
|
SAFFLOWER OIL
LIPOSYN 10% |
NDA | — |
|
SIBUTRAMINE HYDROCHLORIDE
MERIDIA |
NDA | — |
|
AMMONIUM CHLORIDE
AMMONIUM CHLORIDE |
NDA | — |
|
CHLORTHALIDONE
CHLORTHALIDONE |
NDA | — |
|
SUTILAINS
TRAVASE |
NDA | — |
|
PIPOBROMAN
VERCYTE |
NDA | — |
|
AMINO ACIDS, DEXTROSE, MAGNESIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM CHLORIDE, SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
AMINOSYN II 3.5% M IN DEXTROSE 5% IN PLASTIC CONTAINER |
NDA | — |
|
AMINO ACIDS, DEXTROSE, MAGNESIUM CHLORIDE, POTASSIUM CHLORIDE, POTASSIUM PHOSPHATE, DIBASIC, SODIUM CHLORIDE
AMINOSYN II 3.5% W/ ELECTROLYTES IN DEXTROSE 25% IN PLASTIC CONTAINER |
NDA | — |
|
ENFLURANE
ENFLURANE |
NDA | — |
|
DEXTROSE, SODIUM CHLORIDE
DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINER |
NDA | — |
|
DEXTROSE
DEXTROSE 38.5% IN PLASTIC CONTAINER |
NDA | — |
|
PARGYLINE HYDROCHLORIDE
EUTONYL |
NDA | — |
|
OXYTOCIN
OXYTOCIN 20 USP UNITS IN DEXTROSE 5% |
NDA | — |
|
PROTIRELIN
THYPINONE |
NDA | — |
|
ASPIRIN, HYDROCODONE BITARTRATE
VICOPRIN |
NDA | — |
|
CALCIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM CHLORIDE
RINGER'S IN PLASTIC CONTAINER |
NDA | — |
|
AMINO ACIDS, DEXTROSE, MAGNESIUM CHLORIDE, POTASSIUM ACETATE, POTASSIUM CHLORIDE, POTASSIUM PHOSPHATE, DIBASIC, SODIUM CHLORIDE
AMINOSYN II 4.25% W/ ELECT AND ADJUSTED PHOSPHATE IN DEXTROSE 10% IN PLASTIC CONTAINER |
NDA | — |
|
MEPERIDINE HYDROCHLORIDE
MEPERIDINE HYDROCHLORIDE |
NDA | — |
|
ALLOPURINOL
LOPURIN |
NDA | — |
|
CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM ACETATE, SODIUM CHLORIDE
TPN ELECTROLYTES IN PLASTIC CONTAINER |
NDA | — |
|
TETRACYCLINE HYDROCHLORIDE
TETRACYCLINE HYDROCHLORIDE |
NDA | — |
|
THIOPENTAL SODIUM
PENTOTHAL |
NDA | — |
|
PEMOLINE
CYLERT |
NDA | — |
|
LIDOCAINE HYDROCHLORIDE
LIDOCAINE HYDROCHLORIDE |
NDA | Artificial Intelligence Mobile Application, Atherosclerosis, Carotid Artery Diseases, Coronary Artery Disease, End Stage Renal Disease, Prediabetes (Insulin Resistance, Impaired Glucose Tolerance), Renal Failure |
|
BRETYLIUM TOSYLATE
BRETYLIUM TOSYLATE IN DEXTROSE 5% |
NDA | — |
|
EPINEPHRINE, LIDOCAINE HYDROCHLORIDE
LIDOCAINE HYDROCHLORIDE W/ EPINEPHRINE |
NDA | — |
|
GENTAMICIN SULFATE
GENTAMICIN SULFATE |
NDA | — |
|
HYDROCORTISONE SODIUM SUCCINATE
A-HYDROCORT |
NDA | — |
|
AMINO ACIDS, CALCIUM CHLORIDE, DEXTROSE, MAGNESIUM CHLORIDE, POTASSIUM CHLORIDE, POTASSIUM PHOSPHATE, DIBASIC, SODIUM CHLORIDE
AMINOSYN II 4.25% W/ ELECTROLYTES IN DEXTROSE 20% W/ CALCIUM IN PLASTIC CONTAINER |
NDA | — |
|
AMINO ACIDS
AMINOSYN II 3.5% IN PLASTIC CONTAINER |
NDA | — |
|
PROPYLTHIOURACIL
PROPYLTHIOURACIL |
NDA | Acute Coronary Syndrome, Acute Coronary Syndromes, Anemia, Sickle Cell, Benign Prostatic Hyperplasia, Coronary Artery Disease, Coronary Artery Disease (CAD), COVID-19, Healthy, Myocardial Infarction, Neoplasms, Pancreatic Cancer, SARS-CoV2 |
|
AMINO ACIDS, MAGNESIUM ACETATE, POTASSIUM ACETATE, SODIUM CHLORIDE, SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE
AMINOSYN II 3.5% M IN PLASTIC CONTAINER |
NDA | — |
|
ESTAZOLAM
PROSOM |
NDA | — |
|
TERAZOSIN HYDROCHLORIDE
HYTRIN |
NDA | — |
|
RITONAVIR
NORVIR |
NDA | Artificial Intelligence Mobile Application, Atherosclerosis, Carotid Artery Diseases, Coronary Artery Disease, End Stage Renal Disease, Prediabetes (Insulin Resistance, Impaired Glucose Tolerance), Renal Failure |
|
DOPAMINE HYDROCHLORIDE
DOPAMINE HYDROCHLORIDE |
NDA | — |
|
CEPHALOTHIN SODIUM
CEPHALOTHIN SODIUM |
NDA | Acne, Acne Vulgaris, Advanced Cancer, Advanced Solid Tumors, Advanced Solid Tumors or Non-Hodgkin's Lymphoma (NHL), Alopecia, Alzheimer Disease, Alzheimer's Disease, Atopic Dermatitis, Bioequivalence of Amoxicillin, Cancer, Carcinoma, Hepatocellular, Cervical Cancer, Chronic Pruritus, Chronic Refractory Cough, Colitis, Ulcerative, Cough, Cutaneous Inflammation, Dermatitis Atopic, Dermatitis, Chronic, Dermatitis, Seborrheic, Diabetes Mellitus, Type 2, Diaper Rash, Digestive System Disease, Eczema, EGFR Mutated EGFR TKI Naive Metastatic NSCLC, Essential Thrombocythemia, Familial Mediterranean Syndrome, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Gastrointestinal Stromal Tumor (GIST), Hand Dermatosis, Healthy, Healthy Volunteer, Hepatocellular Carcinoma, Hyperhidrosis, Ichthyosis, Lamellar, Kidney Diseases, Lupus Erythematosus, Discoid, Lupus Nephritis, Lymphoma, Lymphoma, Diffuse Large B-Cell, Lymphoma, Non-Hodgkin's, Melanoma, Metabolic Syndrome X, Metastatic Cancer, Metastatic Pancreatic Ductal Ade |
|
SODIUM CHLORIDE
SODIUM CHLORIDE |
NDA | — |
|
DESERPIDINE, METHYCLOTHIAZIDE
ENDURONYL FORTE |
NDA | — |
|
CALCIUM GLUCEPTATE
CALCIUM GLUCEPTATE |
NDA | — |
|
ERYTHROMYCIN LACTOBIONATE
ERYTHROCIN |
NDA | — |
|
AMINO ACIDS, MAGNESIUM ACETATE, PHOSPHORIC ACID, POTASSIUM ACETATE, SODIUM CHLORIDE
AMINOSYN 3.5% M IN PLASTIC CONTAINER |
NDA | — |
|
AMINO ACIDS, DEXTROSE
AMINOSYN 3.5% W/ DEXTROSE 5% IN PLASTIC CONTAINER |
NDA | — |
|
METHYCLOTHIAZIDE, PARGYLINE HYDROCHLORIDE
EUTRON |
NDA | — |
|
METHOXYFLURANE
PENTHRANE |
NDA | — |
Upcoming Catalysts
No upcoming catalysts detected for this company.